Fig. 7From: A macrophage related signature for predicting prognosis and drug sensitivity in ovarian cancer based on integrative machine learningMacrophages-related signature (MRS)-based treatment strategy for ovarian cancer. The level of immune checkpoints (A), HLA-related genes (B), immunophenoscore (C) and TIDE score (D) in ovarian cancer patients with high and low risk score. *p < 0.05, **p < 0.01, ***p < 0.001Back to article page